Heartflow, Inc.
HTFL Healthcare Health Information Services
Heartflow, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $176.0 million, up 39.9% from fiscal 2024.
- Revenue
- +47.6%
- EPS
- +87.7%
- Free cash flow
- +62.6%
Quarter to June 2026, against a year earlier
Follow HTFL
Alert me
Heartflow, Inc. (HTFL) Book value per share
Heartflow, Inc.'s book value per share at the end of fiscal 2025 was 8.2×, compared with −17.0× in fiscal 2024. At the end of the quarter to 30 June 2026 it was 3.2×. Heartflow, Inc. ranks 24th of 44 Health Information Services companies by book value per share.
Book value per share, annual
Embed this chart
Annual newest first
| Period | Book value per share | Change |
|---|---|---|
| FY2025 | 8.2× | — |
| FY2024 | −17.0× | — |
| FY2023 | −1.8× | — |
Quarterly newest first
| Period | Book value per share | Change |
|---|---|---|
| Jun 2026 | 3.2× | (2.96%) |
| Mar 2026 | 3.3× | (59.10%) |
| Dec 2025 | 8.2× | 57.36% |
| Sep 2025 | 5.2× | — |
| 7 more quarters | Free account |
Book value per share against peers
| Company | Book value per share |
|---|---|
| OMCL Omnicell, Inc. compare | 28.7× |
| HQY HealthEquity, Inc. compare | 23.9× |
| WAY Waystar Holding Corp. compare | 21.0× |
| TDOC Teladoc Health, Inc. compare | 7.1× |
| PRVA Privia Health Group, Inc. compare | 6.8× |
| DOCS Doximity, Inc. compare | 5.2× |
| HNGE Hinge Health Inc. compare | 4.4× |
| SDGR Schrodinger, Inc. compare | 4.0× |
| HTFL Heartflow, Inc. | 3.2× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))
More on HTFL
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- The full statement